Junk companies share one thing.....pumptards still trying to pump that the company has the latest and greatest. The facts are: NI studies show efficacy is comparable to current treatment regimes. No superiority outcomes in clinic what so ever!!! Soli was licensed from a now defunct small company that couldn't license to big pharma (sound familiar?). soli is a derivative of an existing class of ABX. CEO is a carsalesman and screwed Longs with offering and dilution. No US partner this late in game is a HUGE red flag. Go it alone strategy will drive pps down below 8 pps. Pro Short interest near 30%......i can go on and on and on....
No the market did not overreact on a failed NI study. The problem now is that it is too difficult to compete in IV only market...Shorts are always right at near 25% short interest...
Longs are pumping hard, learning from pump master Praba herself....the FACTS are Soli is not that special. It is derived from an old class of ABXs and licensed from a small company as none of the big companies were interested. Cemp can't even make a partnership happen because of this and now trying to pump this with the typical tactic of trying to market on own given lack of interest .....amateur strategy and Longs will get burned. Trust Big pharma would be all over this if nPV was attractive. The NI trials are self-explanatory....Nothing superior here folks....current cheap generic ABX classes on market work with similar cure rates. Even the trial of Soli against a FQ can't show any efficacy or safety superiority.
First and foremost.
why don't u compare the safety data from the Soli trial where they used FQ as comparator......why on earth would FDA allow such a horrible safety drug to be used in the clinic under their regulation.....dumb #$%$
U just don't know much.......if the benefit p/risk was negative the FQ class would be off market....period. The fact is FQs continue to work for vast majority with little risk of these SAEs
FQs risk/benefit are still very positive and they work just fine with little risk of one out of a million side effect not captured in trials....all drugs have these. There are many other classes of ABXs (and yes most are generic and cheap) that work solidily against indications that Sol treats..
So where is the data showing Soli superiority against resistance in clinic? Wouldn't it be wise of Cemp to put this the label....ohh wait, they don't have this superiority data do they? It's all about the label in the end....dumb #$%$ Longs
Had that smile since to 40s....will keep smiling knowing how over valued this is!!! Oh, wait insiders sold in 30s so I guess they have a smile tooooo!
Bunch of clowns....did any one mention what their differentiating label claim is going to be based on NI studies....oh wait Praba will keep fingers crossed that Soli will compete against much lower priced generics that have comparable clinical outcomes.....Dumb Longs being taken for a ride and that ride will make me lots of money....LOL
It's amazing the amount of disingenuous borderline fraud in various industries.....it's not only the financial system that is rigged but a bunch of bios like Cemp that take the common folk of their hard earned mulla....I take advantage of this deception.....this is what good shorts do!
That makes the recent offending a nose bleed offering and a bunch of hot air. ABXs by nature of the class (kill microbes and are relatively safe) and thus the regulatory path is significantly de-risked. This won't be propped up much longer....,down, down, down!!!!
Sorry folks have to remind dumb money again....Both NDA submission and approval are already substantially priced in the pps. There will be a consistent drop in pps and Longs will be wondering what happened as this value gets correctly adjusted to market potential of another mee-too competing against countless generic classes that work at comparable cure rates....
Are you finished pumping blindly? End of the day, company doesn't have much and zero pipeline to boot! Just a bunch of pumping to bring in the dumb money....always some body to fall for this garbage....